Streetbeat News

Analyst Ratings

CEVA

Roth MKM analyst Suji Desilva has downgraded CEVA (NASDAQ:CEVA) from Buy to Neutral and lowered the price target from $30 to $20.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:24 pm

TASK

JP Morgan analyst Puneet Jain has downgraded TaskUs (NASDAQ:TASK) from Overweight to Neutral and lowered the price target from $16 to $12.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:23 pm

KLIC

Craig-Hallum analyst Christian Schwab has downgraded Kulicke & Soffa Indus (NASDAQ:KLIC) from Buy to Hold and set a price target of $55.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:22 pm

PBR

HSBC analyst Lilyanna Yang has downgraded Petrobras Brasileiro (NYSE:PBR) from Buy to Hold and announced a $13 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:21 pm

PENN

Truist Securities analyst Barry Jonas maintains a 'Buy' rating on PENN Entertainment (NASDAQ:PENN) but lowers the price target from $33 to $30.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:20 pm

GDRX

DA Davidson analyst Robert Simmons has upgraded GoodRx Holdings (NASDAQ:GDRX) from Neutral to Buy and announced a price target of $9.5.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:10 pm

ADCT

JP Morgan analyst Brian Cheng has upgraded ADC Therapeutics (NYSE:ADCT) from Underweight to Neutral.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:09 pm

ESS

Wells Fargo analyst James Feldman has upgraded Essex Property Trust (NYSE:ESS) from Underweight to Equal-Weight and raised the price target from $208 to $247.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:08 pm

TAST

Stephens & Co. analyst Joshua Long has reiterated an Overweight rating on Carrols Restaurant Group (NASDAQ:TAST) and maintained a $6 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:05 pm

IPSC

Century Therapeutics (NASDAQ:IPSC) reported weaker-than-expected Q2 results, with a loss of 56 cents per share and sales of $99,000, missing estimates. Following the announcement, Chardan Capital, HC Wainwright & Co., and EF Hutton revised their price targets for the company's shares.

Portfolio Pulse from Lisa Levin

August 10, 2023 | 12:05 pm